Covid-19 Cepiva

Uporabnik McGiver je napisal:

Komedija zmešnjav - če v resnici ne bi bilo žalostno! Najprej se ne sme cepit starejše od 65 let, sedaj ne mlajše od 60 let.

Berlin ustavlja cepljenje s cepivom AstraZenece pri mlajših od 60 let, komisija je izdala enako priporočilo za celo Nemčijo

V Nemčiji so zabeležili 31 primerov krvnih strdkov v možganih, devet od teh se je končalo s smrtjo.

www.vecer.com

OK še vedno očitno čakam na Sputnik, ampak sedaj Light.

Klikni za razširitev

Uporabnik AndY1 je napisal:

Za kaj pa?

Klikni za razširitev

Uporabnik AndY1 je napisal:

Boste mlajši od 60 let, ki ste že bili cepljeni z AZ, dobili tudi drugo dozo AZ ali ne

Klikni za razširitev

Uporabnik endvatri je napisal:

Pa večerovi novinarji.

Klikni za razširitev

Uporabnik Matey je napisal:

A to so zamenjali ime, da bi ga lažje prodajali še naprej? Češ "težave s krvnimi strdki so pri AstraZeneci, to zdaj je pa Vaxzevria"?

Klikni za razširitev

Uporabnik doctorz je napisal:

Ker je eno dati cloveku palcko v nos, drugo pa je injecirati zdravilo. Pred cepljenjem mora osebni zdravnik potrditi, da si zdrav in da se lahko cepis. Glede na to, da si ze bil kdaj v zivljenju cepljen,verjetno ves kako to poteka.
Ce si pa cisto izven tega vprasaj nekoga, ki je pred kratkim peljal otroka na cepljenje.
Se nekaj bi komentiral glede cepljenja v kocevju- tam dela primoz, ki zivi za sluzbo in mu ni problem delati po 48 ur skupaj, imajo dovolj osebja in dovolj prostora. Ne delajo veliko testov na covid kot recimo nekje drugje.
Pol pa spet druga stran zgodbe, ta isti primoz ki dela po 300 ur na mesec zato da cepi cimvec ljudi, dobi covid dodatka 1000 eur, ga pa ljudje zmerjajo za lopova, da se mu gre samo za denar itd itd.... pol pa bodi pameten.

Klikni za razširitev

Uporabnik bizi je napisal:

Ja no, mene je Primož po telefonu vprašal, če sem zdrav in ko sem potrdil, so me cepili še isti dan. Osebnega zdravnika imam v Ljubljani, tako da mojega zdravja sigurno ni mogel potrditi.

Klikni za razširitev

Uporabnik AndY1 je napisal:

Govori o te nemški študiji o strdkih:

A Prothrombotic Thrombocytopenic Disorder Resembling Heparin-Induced Thrombocytopenia Following Coronavirus-19 Vaccination

Background. Vaccines are important for managing the COVID-19 pandemic caused by SARS-CoV-2. However, following widespread vaccination using a recombinant adenoviral vector encoding the spike protein antigen of SARS-CoV-2 (AZD1222, AstraZeneca), reports have emerged of some vac...

www.researchsquare.com

Nazorno pokaže dejastva iz te študije in v drugi polovici tudi pove, kakšna so zdravila za reševanje teh strdkov. Dejansko naredi povzetek te študije.

Klikni za razširitev

There are several important clinical implications of our findings. First, clinicians should be aware that onset of (venous or arterial) thrombosis particularly at unusual sites such as in the brain or abdomen and thrombocytopenia beginning approximately 5 to 14 days after vaccination can represent a rare adverse effect of preceding COVID-19 vaccination. To date, this has only been reported with the AZD1222 vaccine. Second, enzyme-immunoassays for heparin-induced thrombocytopenia are widely available and based on our observations can be used to investigate for potential post-vaccination anti-PF4 antibody associated thrombocytopenia/thrombosis, especially as a strong-positive immunoassay result obtained in a patient who has not been recently exposed to heparin would be a striking abnormality. However, a positive PF4/heparin antigen test by no means confirms the presence of potentially pathogenic vaccine-induced antibodies, especially if the assay is moderate or weak positive, and thus referral to a laboratory that performs platelet-activation assays should be performed. Without clear clinical symptoms of new thrombosis and/or thrombocytopenia patients should not be tested or treated. Third, although this syndrome differs from typical heparin-induced thrombocytopenia, at least one patient showed strong platelet activation in the presence of heparin. In the absence of data indicating safety and efficacy of heparin in treating these patients13, we would recommend therapy with non-heparin anticoagulants, such as those direct oral anticoagulants (rivaroxaban, apixaban) which are licensed without requirement for initial heparin therapy. Indeed, direct oral anticoagulants are widely used for treatment of thrombosis in general and have also been recommended for treatment of heparin-induced thrombocytopenia. And fourth, our in vitro studies of inhibition of the platelet-activating properties by high-dose immunoglobulin, together with the recent observations indicating efficacy of high-dose intravenous immunoglobulin for treating severe heparin-induced thrombocytopenia—including so-called “autoimmune heparin-induced thrombocytopenia” in which patients have de novo or ongoing thrombocytopenia in the absence of heparin—suggests that this can be an important treatment adjunct in a patient who develops life-threatening thrombotic event such as cerebral vein sinus thrombosis post-vaccination9,14,15. Finally we suggest to name this entity vaccine induced prothrombotic immune thrombocytopenia (VIPIT) to avoid confusion with heparin-induced thrombocytopenia (HIT).

Klikni za razširitev

Uporabnik AndY1 je napisal:

Govori o te nemški študiji o strdkih:

A Prothrombotic Thrombocytopenic Disorder Resembling Heparin-Induced Thrombocytopenia Following Coronavirus-19 Vaccination

Background. Vaccines are important for managing the COVID-19 pandemic caused by SARS-CoV-2. However, following widespread vaccination using a recombinant adenoviral vector encoding the spike protein antigen of SARS-CoV-2 (AZD1222, AstraZeneca), reports have emerged of some vac...

www.researchsquare.com

Nazorno pokaže dejastva iz te študije in v drugi polovici tudi pove, kakšna so zdravila za reševanje teh strdkov. Dejansko naredi povzetek te študije.

Klikni za razširitev